Epsium Enterprise Ltd is a US-listed company in the beverages industry. Its financial year ends in December.
Loading chart…
Third-party market data · may be delayed
Under review: share count (3m) is 0.22x the cover-page count (12m).
Under review: share count (3m) is 0.22x the cover-page count (12m). We'll show the comparison once resolved.
Epsium Enterprise Ltd valuation: adjust assumptions and compare models →
What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.
Revenue for the twelve months was $5m. That puts it 25 of 26 for growth among the beverages companies we cover. Free-cash-flow margin held at -46.6%. Against its peers on growth, profitability, cash generation and balance sheet, it grades D. It passes 2 of our 2 financial-health checks.
Our model value for Epsium Enterprise is under review, so past values are not shown until it is resolved.
Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.
Epsium Enterprise Ltd's trailing-twelve-month revenue fell 59.1% year on year, with a free-cash-flow margin of -46.6%. Where it stands out: days sales outstanding of 14 days ranks 3 of 21 beverages companies we cover. Where it lags: revenue growth of -59.1% ranks 25 of 26 beverages companies we cover.
Current signal Operating margin compressing: TTM operating margin fell to -29.2%, down 32.5pp year over year.
Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.
Loading chart…
Third-party market data · may be delayed
Company announcements, filed results and changes that matter to shareholders.
No recent updates are available for EPSM from the sources we follow. See filings →
Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Low.
No analyst estimates are published for Epsium Enterprise Ltd: too few analysts cover it.
| Calendar year | 2026 to date |
|---|---|
| Return | |
| EPSM | −59% |
| Industry peers (median) | −2% |
| S&P 500 | +11% |
| Months that ended higher | |
| EPSM | 46% |
| S&P 500 | 46% |
| Largest fall from a high during the year | |
| EPSM | −70% |
| S&P 500 | −9% |
Worst fall since March 26, 2025: 99% from September 9, 2025 to October 30, 2026. Getting back needed a 16688% gain, and the shares have not yet recovered.
Source: SEC EDGAR filings. Retrieved Invalid Date.
| Period | Revenue (TTM) |
|---|---|
| FY22 Q4 | $11.2M |
| FY23 Q4 | $29.2M |
| FY24 Q4 | $12.5M |
| FY25 Q4 | $5.1M |
Source: SEC EDGAR filings. Retrieved Invalid Date.
| Period | Operating margin (TTM) |
|---|---|
| FY22 Q4 | 11.1% |
| FY23 Q4 | 14.8% |
| FY24 Q4 | 3.3% |
| FY25 Q4 | -29.2% |
Source: SEC EDGAR filings. Retrieved Invalid Date.
| Period | FCF margin (TTM) |
|---|---|
| FY22 Q4 | 12.5% |
| FY23 Q4 | 6.4% |
| FY24 Q4 | -11.8% |
| FY25 Q4 | -46.6% |
| Fiscal year | 2022 Dec 2022 | 2023 Dec 2023 | 2024 Dec 2024 | 2025 Dec 2025 |
|---|---|---|---|---|
| Income | ||||
| Revenue | 11 | 29 | 13 | 5 |
| Gross profit | 2 | 6 | 2 | 1 |
| EBITDA | 1 | 4 | 0 | −1 |
| Operating income | 1 | 4 | 0 | −1 |
| Net income | 1 | 4 | 0 | −1 |
| Diluted EPS | $0.09 | $0.31 | $0.02 | — |
| Growth (year on year) | ||||
| Revenue | — | +161.3% | −57.1% | −59.1% |
| EBITDA | — | +245.3% | −90.3% | −448.6% |
| Operating income | — | +250.0% | −90.6% | −466.8% |
| Net income | — | +228.8% | −92.5% | −644.9% |
| Diluted EPS | — | +244.4% | −93.5% | — |
| Margins | ||||
| Gross margin | 17.2% | 19.0% | 12.8% | 14.7% |
| EBITDA margin | 11.3% | 14.9% | 3.4% | −28.8% |
| Operating margin | 11.1% | 14.8% | 3.3% | −29.2% |
| Net margin | 10.0% | 12.6% | 2.2% | −29.3% |
| Free-cash-flow margin | 12.5% | 6.4% | −11.8% | −46.6% |
| Cash flow | ||||
| Cash from operations | 1 | 2 | −1 | −2 |
| Capital spending | 0 | 0 | 0 | 0 |
| Free cash flow | 1 | 2 | −1 | −2 |
| Balance sheet | ||||
| Cash | 1 | 1 | 0 | 2 |
| Total debt | 0 | 0 | 0 | 0 |
| Net debt (negative = net cash) | −1 | −1 | −0 | −2 |
| Diluted shares | 12m | 12m | 12m | — |
| Returned to shareholders | ||||
| Buybacks | — | — | — | 0 |
| Total returned | — | — | — | 0 |
| Last 12 months unless stated | EPSM | AGCC | WNW | IBG | IPST | YHC | Median |
|---|---|---|---|---|---|---|---|
| Revenue, last 12 months | $5m | $6m | $7m | $3m | $10m | $1m | $723m |
| Revenue growth, last 12 months | −59.1% | 144.6% | >999% | −5.1% | 39.7% | −49.6% | 6.6% |
| Revenue growth, latest quarter | — | — | — | — | −44.3% | −30.6% | 6.4% |
| Gross margin | 14.7% | 30.4% | 10.1% | 44.2% | 65.4% | 6.5% | 42.6% |
| Operating margin | −29.2% | 12.6% | −124.1% | −194.2% | <−999% | −908.3% | −0.9% |
| Operating margin, 3-year average | — | — | — | — | −801.6% | −860.1% | 11.9% |
| Net margin | −29.3% | 9.8% | −262.5% | −223.4% | <−999% | <−999% | −1.6% |
| Cash from operations / revenue | −46.5% | −120.8% | 127.6% | −56.3% | −164.4% | <−999% | 9.9% |
| Free-cash-flow margin | −46.6% | — | 127.6% | −56.7% | −164.9% | — | 9.0% |
| Stock pay / revenue | — | — | 11.7% | 71.1% | 35.7% | 168.0% | 1.2% |
| Change in share count | 0.0% | 27.3% | 95.8% | 41.7% | — | — | 0.0% |
| Measure | Company | Peer median | Rank |
|---|---|---|---|
| Revenue growth Growth | -59.1% | 6.9% | 25 of 26 |
| Change in growth rate Growth | -2.0pp | +0.6pp | 19 of 26 |
| Gross margin Profitability | 14.7% | 44.2% | 23 of 26 |
| Operating margin Profitability | -29.2% | -0.7% | 19 of 26 |
| Net margin Profitability | -29.3% | -1.5% | 19 of 26 |
| Free-cash-flow margin Cash generation | -46.6% | 9.6% | 20 of 24 |
| Change in share count Balance sheet | 0.0% | 0.0% | 10 of 19 |
| Days sales outstanding Balance sheet | 14 days | 33 days | 3 of 21 |
Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).
| Manager | Value | Shares | Share of 13F value | Shares QoQ |
|---|---|---|---|---|
| HRT Financial LP | $109,000 | 90K | 62.3% | New |
| Jane Street Group, LLC | $49,585 | 41K | 28.4% | New |
| Xtx Topco Ltd | $15,610 | 13K | 8.9% | ▼ 23.4% |
| Morgan Stanley | $304 | 0K | 0.2% | 0.0% |
| UBS Group AG | $269 | 0K | 0.2% | ▼ 65.1% |
| BNP Paribas Financial Markets | $70 | 0K | 0.0% | 0.0% |
| Caitong International Asset Management Co., Ltd | $10 | 0K | 0.0% | ▲ 33.3% |
From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Epsium Enterprise Ltd's complete shareholder register. Values are as reported by the filers .
From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.
| Data | Last updated | Source |
|---|---|---|
| Share price | Exchange closing prices | |
| News and updates | Company releases and SEC 8-K filings | |
| Analyst estimates | Aggregated analyst estimates | |
| Valuation and scores | Our models, from the filed figures |
New research on the companies we cover arrives in the weekly email. Free, one email a week.
